Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement

Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.

Full text not available from this repository.
Item Type: Article
Status: Published
Official URL: https://doi.org/10.1016/j.hlc.2020.04.006
Journal or Publication Title: Heart, Lung and Circulation
Volume: 29
Number: 7
Page Range: e85-e87
Date: 2020
Divisions: Cardio Genomics
Molecular Cardiology
Depositing User: General Admin
Identification Number: 10.1016/j.hlc.2020.04.006
ISSN: 14439506
Date Deposited: 04 Jan 2021 03:33
Abstract:

In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care.

Creators:
Creators
Email
Gray, Belinda
UNSPECIFIED
Semsarian, Christopher
UNSPECIFIED
Fatkin, Diane
UNSPECIFIED
Ingles, Jodie
UNSPECIFIED
Atherton, John J.
UNSPECIFIED
Davis, Andrew M.
UNSPECIFIED
Sanders, Prashanthan
UNSPECIFIED
Pachter, Nicholas
UNSPECIFIED
Skinner, Jonathan R.
UNSPECIFIED
Stiles, Martin K.
UNSPECIFIED
Last Modified: 04 Jan 2021 03:33
URI: https://eprints.centenary.org.au/id/eprint/738

Actions (login required)

View Item View Item